The Over-The-Counter Drugs Market is expected to register a CAGR of 5.7% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the over-the-counter (OTC) drugs market is categorized by product type into analgesics, cold and flu medications, gastrointestinal drugs, and others. Applications include pain management, respiratory conditions, digestive health, and others. Distribution channels analyzed include pharmacies, online retailers, and supermarkets. The regional analysis spans key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market valuation is provided in US$ for all segmental analyses.
Purpose of the ReportThe report Over-The-Counter Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Over-The-Counter Drugs Market Segmentation
Product Type- Dermatology Products
- Weight-loss or Dietary Products
- Sleeping Aids
- Gastrointestinal Products
- Cough
- Cold
- Flu Products
- Analgesics
- Vitamins
- Mineral
- Supplements
- Ophthalmic Products
- Other Product Types
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacy
- Other Distribution Channels
Strategic Insights
Over-The-Counter Drugs Market Growth Drivers- Increasing cost of healthcare: One of the main reasons behind OTC drugs markets is increasing costs of healthcare and self-medication desire. The continually increasing cost of healthcare, which in turn increases visitation charges as well as pharmaceutical prescription, tends to force more patients to rely on OTC products for cheaper medical treatment. OTC drugs enable people to treat minor ailments at home without having to visit a doctor, which cuts down on overall healthcare spending. A study by the National Center for Biotechnology Information suggests that self-medication is gaining popularity, especially in developed countries where healthcare systems are overstretched. The increasing need for more accessible, affordable treatment solutions is expected to further drive the requirement for OTC drugs in virtually all the above-mentioned therapeutic fields.
- Consumer consciousness and access: With increasing health consciousness and wellness awareness among consumers, an increased focus will be placed upon proactive self-initiated care involving the use of OTC products. This is driven by factors such as increased access to information through the internet and social media platforms, which educate consumers about common ailments and available OTC solutions. For instance, many consumers now prefer using natural or homeopathic remedies for conditions such as colds or digestive issues, thereby increasing demand for OTC products. The rise in online pharmacies and retail outlets, both physical and digital, is making OTC drugs more accessible. Consumers can now easily purchase these products from supermarkets, pharmacies, or online platforms, contributing to the overall growth of the market.
- Aging Population and Chronic Disease Management: The global population is aging, which is contributing to the increasing demand for OTC drugs. Chronic diseases including arthritis, diabetes, hypertension, and gastrointestinal diseases affect the aged and are most managed through OTC medicines. In addition, chronic patients have the possibility of maintaining an independent and personal form of managing their condition if the drug available over the counter does not require direct physician intervention or administration. As the World Health Organization (WHO) estimates that the global population aged 60 years or older will nearly double by 2050, the demand for OTC medications, particularly those targeted at age-related conditions, is expected to increase.
- Shifting to More Natural and Herbal Products: Demand in the market of OTC drugs is witnessed a growing concern about the product in the increasing category of organic and herbal offerings. More customers become health-minded as they stop buying artificial products and increasingly buy natural alternatives or plant-based goods. Among other items gaining preference, herbs are now fast catching up through homeopathic goods, dietary supplements, and general well-being care items. The rise of the natural trend in health is essentially driven by increasing consumer concerns about synthetic, pharmaceutical-based drugs and their side effects, and a desire for more holistic approaches to health. In response to these movements, companies offer OTC products containing a plank of ingredients, such as using turmeric for inflammation, ginger for digestion, or echinacea for immune support.
- Online Sales Revolutionize the OTC Drug Market Amid E-Commerce Growth: E-commerce and growth of online sales are the most significant factors altering the OTC drug market. Online pharmacies, health retailers, and more importantly, big e-commerce companies like Amazon, Walmart, and specialized chains of the drugstore have revolutionized consumerism by allowing consumers a convenient method for buying OTC drugs. Ease of surfing, ordering, and getting product-delivered home has shifted most consumers' preference to online. Additionally, there have been rapid advancements related to online sales of health products due to the COVID-19 pandemic, as customers try to avoid coming into stores. A report by Statista reveals a gigantic expansion of the e-pharmacy market globally in upcoming years, illustrating the increased need for digitized channels for selling over-the-counter medicines.
- Emergence of Personalized OTC Healthcare Products: Increasingly, personalized over-the-counter healthcare products are taking the market toward individualized consumers. Customization is becoming popular, and firms are offering individualized vitamins, supplements, and OTC treatments, depending on a person's age, gender, health conditions, and lifestyle. For instance, companies are applying consumer data and technology to advise personalized healthcare products, such as specially designed multivitamins or probiotics. This trend is further fueled by increasing availability of personal healthcare information and the demand for more individualized health solutions. Personalized OTC healthcare products are likely to continue growing as consumers seek more targeted and effective treatments.
- Partnering with local Retailers for expansion: This offers an enormous expansion opportunity in making the OTC drugs available for rural and underserved markets. Many developing countries as well as rural communities face the issues of restricted access to prescription drugs as well as the services of a doctor. With the availability of an OTC, a huge section can easily obtain one without any kind of prescription. Manufacturers and distributors can take advantage of these underdeveloped markets by partnering with local retail outlets and improving the distribution channels. Moreover, governments and NGOs can contribute to making essential OTC drugs available in these regions, thereby fueling market growth.
- Technological Advancements and Digital Health Integration: The integration of digital technologies and mobile health platforms with OTC drug offerings is another area of opportunity. Mobile health apps and digital platforms are being used in monitoring health, reminding patients about their medication intakes, and information about the symptoms and treatments of a particular disease. This integration of digital health tools with OTC drugs may offer consumers the most personalized and efficient healthcare solutions possible. Such an application of tracking the efficiency of over-the-counter products, offering feedback about dosages, and providing alternative remedies would represent significant growth opportunities. Furthermore, developing smart packaging that can track product use or ensure dosages will be an attractive prospect.
- Rising Demand for Preventive Healthcare: The widespread focus on preventive healthcare is an opportunity for OTC companies to offer products aligned with wellness and health maintenance. Consumers increasingly seek products that prevent illnesses instead of just treating them after they have happened. This shift alone is boosting the demand for OTC vitamins, minerals, probiotics, and supplements focusing on immunity boosters, digestive support, and enhancing overall wellbeing. This trend of focusing on prevention will allow companies to cash in by providing preventive OTC health care solutions.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Over-The-Counter Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Over-The-Counter Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Over-The-Counter Drugs Market is expected to register a CAGR of 5.7% from 2025-2031.
The major driving factors supporting the Over-The-Counter Drugs market growth are - - Increasing Cost of Healthcare, Consumer Consciousness and Access, Aging Population and Chronic Disease Management
Key future trends in the Over-The-Counter Drugs Market are -
Key companies in the Over-The-Counter Drugs Market are- , Alkem Health Care, Bayer CropScience Limited, Cipla Inc., GlaxoSmithKline plc., Glenmark Pharmaceuticals Limited, Ipsen Pharma, Pfizer Inc., Procter & Gamble, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Over-the-Counter Drugs Market - By Product Type
1.3.2 Over-the-Counter Drugs Market - By Distribution Channel
1.3.3 Over-the-Counter Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. OVER-THE-COUNTER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. OVER-THE-COUNTER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. OVER-THE-COUNTER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. OVER-THE-COUNTER DRUGS - GLOBAL MARKET OVERVIEW
6.2. OVER-THE-COUNTER DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. OVER-THE-COUNTER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DERMATOLOGY PRODUCTS
7.3.1. Overview
7.3.2. Dermatology Products Market Forecast and Analysis
7.4. WEIGHT-LOSS OR DIETARY PRODUCTS
7.4.1. Overview
7.4.2. Weight-loss or Dietary Products Market Forecast and Analysis
7.5. SLEEPING AIDS
7.5.1. Overview
7.5.2. Sleeping Aids Market Forecast and Analysis
7.6. GASTROINTESTINAL PRODUCTS
7.6.1. Overview
7.6.2. Gastrointestinal Products Market Forecast and Analysis
7.7. COUGH, COLD, AND FLU PRODUCTS
7.7.1. Overview
7.7.2. Cough, Cold, and Flu Products Market Forecast and Analysis
7.8. ANALGESICS
7.8.1. Overview
7.8.2. Analgesics Market Forecast and Analysis
7.9. VITAMINS, MINERAL, AND SUPPLEMENTS (VMS)
7.9.1. Overview
7.9.2. Vitamins, Mineral, and Supplements (VMS) Market Forecast and Analysis
7.10. OPHTHALMIC PRODUCTS
7.10.1. Overview
7.10.2. Ophthalmic Products Market Forecast and Analysis
7.11. OTHER PRODUCT TYPES
7.11.1. Overview
7.11.2. Other Product Types Market Forecast and Analysis
8. OVER-THE-COUNTER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACY
8.5.1. Overview
8.5.2. Online Pharmacy Market Forecast and Analysis
8.6. OTHER DISTRIBUTION CHANNELS
8.6.1. Overview
8.6.2. Other Distribution Channels Market Forecast and Analysis
9. OVER-THE-COUNTER DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Over-the-Counter Drugs Market Overview
9.1.2 North America Over-the-Counter Drugs Market Forecasts and Analysis
9.1.3 North America Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.1.4 North America Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Over-the-Counter Drugs Market
9.1.5.1.1 United States Over-the-Counter Drugs Market by Product Type
9.1.5.1.2 United States Over-the-Counter Drugs Market by Distribution Channel
9.1.5.2 Canada Over-the-Counter Drugs Market
9.1.5.2.1 Canada Over-the-Counter Drugs Market by Product Type
9.1.5.2.2 Canada Over-the-Counter Drugs Market by Distribution Channel
9.1.5.3 Mexico Over-the-Counter Drugs Market
9.1.5.3.1 Mexico Over-the-Counter Drugs Market by Product Type
9.1.5.3.2 Mexico Over-the-Counter Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Over-the-Counter Drugs Market Overview
9.2.2 Europe Over-the-Counter Drugs Market Forecasts and Analysis
9.2.3 Europe Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.2.4 Europe Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Over-the-Counter Drugs Market
9.2.5.1.1 Germany Over-the-Counter Drugs Market by Product Type
9.2.5.1.2 Germany Over-the-Counter Drugs Market by Distribution Channel
9.2.5.2 France Over-the-Counter Drugs Market
9.2.5.2.1 France Over-the-Counter Drugs Market by Product Type
9.2.5.2.2 France Over-the-Counter Drugs Market by Distribution Channel
9.2.5.3 Italy Over-the-Counter Drugs Market
9.2.5.3.1 Italy Over-the-Counter Drugs Market by Product Type
9.2.5.3.2 Italy Over-the-Counter Drugs Market by Distribution Channel
9.2.5.4 Spain Over-the-Counter Drugs Market
9.2.5.4.1 Spain Over-the-Counter Drugs Market by Product Type
9.2.5.4.2 Spain Over-the-Counter Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Over-the-Counter Drugs Market
9.2.5.5.1 United Kingdom Over-the-Counter Drugs Market by Product Type
9.2.5.5.2 United Kingdom Over-the-Counter Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Over-the-Counter Drugs Market Overview
9.3.2 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Over-the-Counter Drugs Market
9.3.5.1.1 Australia Over-the-Counter Drugs Market by Product Type
9.3.5.1.2 Australia Over-the-Counter Drugs Market by Distribution Channel
9.3.5.2 China Over-the-Counter Drugs Market
9.3.5.2.1 China Over-the-Counter Drugs Market by Product Type
9.3.5.2.2 China Over-the-Counter Drugs Market by Distribution Channel
9.3.5.3 India Over-the-Counter Drugs Market
9.3.5.3.1 India Over-the-Counter Drugs Market by Product Type
9.3.5.3.2 India Over-the-Counter Drugs Market by Distribution Channel
9.3.5.4 Japan Over-the-Counter Drugs Market
9.3.5.4.1 Japan Over-the-Counter Drugs Market by Product Type
9.3.5.4.2 Japan Over-the-Counter Drugs Market by Distribution Channel
9.3.5.5 South Korea Over-the-Counter Drugs Market
9.3.5.5.1 South Korea Over-the-Counter Drugs Market by Product Type
9.3.5.5.2 South Korea Over-the-Counter Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Over-the-Counter Drugs Market Overview
9.4.2 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Over-the-Counter Drugs Market
9.4.5.1.1 South Africa Over-the-Counter Drugs Market by Product Type
9.4.5.1.2 South Africa Over-the-Counter Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Over-the-Counter Drugs Market
9.4.5.2.1 Saudi Arabia Over-the-Counter Drugs Market by Product Type
9.4.5.2.2 Saudi Arabia Over-the-Counter Drugs Market by Distribution Channel
9.4.5.3 U.A.E Over-the-Counter Drugs Market
9.4.5.3.1 U.A.E Over-the-Counter Drugs Market by Product Type
9.4.5.3.2 U.A.E Over-the-Counter Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Over-the-Counter Drugs Market Overview
9.5.2 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis
9.5.3 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Over-the-Counter Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Over-the-Counter Drugs Market
9.5.5.1.1 Brazil Over-the-Counter Drugs Market by Product Type
9.5.5.1.2 Brazil Over-the-Counter Drugs Market by Distribution Channel
9.5.5.2 Argentina Over-the-Counter Drugs Market
9.5.5.2.1 Argentina Over-the-Counter Drugs Market by Product Type
9.5.5.2.2 Argentina Over-the-Counter Drugs Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. OVER-THE-COUNTER DRUGS MARKET, KEY COMPANY PROFILES
11.1. ALKEM HEALTH CARE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAYER CROPSCIENCE LIMITED
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CIPLA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLENMARK PHARMACEUTICALS LIMITED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. IPSEN PHARMA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PROCTER AND GAMBLE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SUN PHARMACEUTICAL INDUSTRIES LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Alkem Health Care
2. Bayer CropScience Limited
3. Cipla Inc.
4. GlaxoSmithKline plc.
5. Glenmark Pharmaceuticals Limited
6. Ipsen Pharma
7. Pfizer Inc.
8. Procter & Gamble
9. Sun Pharmaceutical Industries Ltd.
10. Teva Pharmaceutical Industries Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For